Planta Med 2011; 77(14): 1663-1667
DOI: 10.1055/s-0030-1270932
Biological Screening
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

In vitro Screening of Traditional South African Malaria Remedies against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum

Tsholofelo A. Mokoka1 , Stefanie Zimmermann2 , 3 , Tasqiah Julianti2 , 5 , Yoshie Hata2 , 6 , Nivan Moodley1 , Monica Cal3 , Michael Adams2 , Marcel Kaiser3 , Reto Brun3 , Neil Koorbanally4 , Matthias Hamburger2
  • 1Biosciences, CSIR, Pretoria, South Africa
  • 2Institute of Pharmaceutical Biology, University of Basel, Basel, Switzerland
  • 3Swiss Tropical and Public Health Institute, Basel, Switzerland
  • 4School of Chemistry, University of KwaZulu-Natal, Durban, South Africa
  • 5Faculty of Pharmacy, Pancasila University, Jakarta, Indonesia
  • 6Departamento de Farmacia, Universidad Nacional de Colombia, Bogotá, Colombia
Further Information

Publication History

received January 10, 2011 revised February 24, 2011

accepted February 26, 2011

Publication Date:
16 March 2011 (online)

Abstract

Three hundred extracts were prepared from plants traditionally used in South Africa to treat malaria and screened in vitro for activity against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Leishmania donovani, and Plasmodium falciparum. For the 43 extracts which inhibited the growth of one or more parasites to more than 95 % at 9.7 µg/mL, the IC50 values against all four protozoal parasites and cytotoxic IC50s against rat myoblast L6 cells were determined. Amongst the most notable results are the activities of Agathosma apiculata (IC50 of 0.3 µg/mL) against Plasmodium falciparum, as well as Salvia repens and Maytenus undata against Leishmania donovani with IC50s of 5.4 µg/mL and 5.6 µg/mL, respectively. This screening is the starting point for a HPLC-based activity profiling project in antiprotozoal lead discovery.

References

  • 1 Chirac P, Torreele E. Global framework on essential health R & D.  Lancet. 2006;  367 1560-1561
  • 2 Stuart K, Brun R, Croft S, Fairlamb A, Gürtler R E, McKerrow J, Reed S, Tarleton R. Kinetoplastids: related protozoan pathogens, different diseases.  J Clin Invest. 2008;  118 1301-1310
  • 3 World Health Organization .Drug resistance: malaria. Available at. http://www.who.int/drugresistance/malaria/en/ Accessed February 21, 2011
  • 4 http://www.mmv.org/ Accessed February 21, 2011
  • 5 http://www.gatesfoundation.org/Pages/home.aspx Accessed February 21, 2011
  • 6 Clarkson C, Maharaj V J, Crouch N R, Grace O M, Pillay P, Matsabisa M G, Bhagwandin N, Smith P J, Folb P I. In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa.  J Ethnopharmacol. 2004;  92 177-191
  • 7 Baltz T, Baltz D, Giroud C, Crockett J. Cultivation in a semidefined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense, T. gamiense.  EMBO J. 1985;  4 1273-1277
  • 8 Räz B, Iten M, Grether-Bühler Y, Kaminsky R, Brun R. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro.  Acta Trop. 1997;  68 139-147
  • 9 Buckner F S, Verlinde C L, La Flamme A C, Van Voorhis W C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase.  Antimicrob Agents Chemother. 1996;  40 2592-2597
  • 10 Adams M, Zimmermann S, Kaiser M, Brun R, Hamburger M. A protocol for HPLC-based activity profiling for natural products with activities against tropical parasites.  Nat Prod Commun. 2009;  4 1377-1381
  • 11 Trager W, Jensen J B. Human malaria parasites in continuous culture.  Science. 1976;  193 673-675
  • 12 Potterat O, Hamburger M. Natural products in drug discovery – concepts and approaches for tracking bioactivity.  Curr Org Chem. 2006;  8 899-920
  • 13 Adams M, Christen M, Zimmermann S, Plitzko I, Kaiser M, Brun R, Hamburger M. New antiplasmodial lanostanes from Ganoderma lucidum mushroom.  J Nat Prod. 2010;  73 897-900
  • 14 Ślusarczyk S, Zimmermann S, Kaiser M, Matkowski A, Hamburger M, Adams M. Antiplasmodial and antitrypanosomial activity of tanshinone-type diterpenoids from Salvia miltiorrhiza.  Planta Med. 2011;  DOI: 10.1055/s-0030-1270933
  • 15 Adams M, Plitzko I, Kaiser M, Brun R, Hamburger M. 3-methoxy carpachromene – a new tetracyclic flavonol from Pistacia atlantica with anti plasmodial activity.  Phytochem Lett. 2009;  2 159-162

Prof. Dr. Matthias Hamburger

Department of Pharmaceutical Sciences
Institute of Pharmaceutical Biology
University of Basel

Klingelbergstrasse 50

4056 Basel

Switzerland

Phone: +41 6 12 67 15 55

Fax: +41 6 12 67 14 74

Email: matthias.hamburger@unibas.ch

>